Life-Threatening and Fatal Adverse Drug Events in a Danish University Hospital

被引:7
|
作者
Tchijevitch, Olga A. [1 ]
Nielsen, Lars Peter [1 ]
Lisby, Marianne [2 ]
机构
[1] Aarhus Univ Hosp, Dept Clin Pharmacol, Noerrebrogade 44, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp, Res Ctr Emergency Med, Aarhus, Denmark
关键词
adverse events; trigger tool; patient safety; medication safety; incident reporting; TRIGGER TOOL; CARE; DEATHS;
D O I
10.1097/PTS.0000000000000411
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives Detection of adverse drug events (ADEs) in Danish hospitals relies on health care professionals' incident reporting to a national database for adverse events, but the method is incomplete; thus, fatal and life-threatening ADEs may remain unrecognized. The objectives of this study were to examine the occurrence of life-threatening and fatal ADEs in population of hospitalized patients with suspected adverse outcome and to compare these findings with the actual number of reported ADEs in the study period of 3 months. Methods Study was designed as a cross-sectional study of adult population, hospitalized for more than 24 hours, having an unplanned transfer to an intensive care unit (ICU), or having unexpected death. Medical records were retrospectively screened by the Global Trigger Tool. All positive triggers were assessed for ADEs by a clinical pharmacologist. Results Of the 26,176 patients admitted in the study period, 105 had an unplanned transfer to the ICU and 36 died unexpectedly. In total, 15 positive triggers were identified in 10 patients. Life-threatening ADEs accounted for 7.6% (8/105) of patients transferred to the ICU, and fatal ADEs constituted 5.5% (2/36) of the deceased patients. Life-threatening and fatal ADEs corresponded to an overall prevalence of 0.04% (10/26,176). Most ADEs were related to hemorrhages and respiratory problems. No serious or fatal ADEs were reported in the incident reporting system in the study period. Conclusions Ten life-threatening and fatal ADEs were uncovered as not reported in the incident reporting system. Further steps are needed for recognition and prevention of this patient safety challenge.
引用
收藏
页码:e562 / e567
页数:6
相关论文
共 50 条
  • [41] Life-Threatening Endocrinological Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy
    Basek, Aleksandra
    Jakubiak, Grzegorz K.
    Cieslar, Grzegorz
    Stanek, Agata
    CANCERS, 2023, 15 (24)
  • [42] Hypomagnesemia as a potentially life-threatening adverse effect of omeprazole
    Hansen, Bent-Are
    Bruserud, Oyvind
    OXFORD MEDICAL CASE REPORTS, 2016, (07): : 147 - 149
  • [43] Incidence and Management of Life-Threatening Adverse Events During Cardiac Catheterization for Congenital Heart Disease
    Lin, C. Huie
    Hegde, Sanjeet
    Marshall, Audrey C.
    Porras, Diego
    Gauvreau, Kimberlee
    Balzer, David T.
    Beekman, Robert H., III
    Torres, Alejandro
    Vincent, Julie A.
    Moore, John W.
    Holzer, Ralf
    Armsby, Laurie
    Bergersen, Lisa
    PEDIATRIC CARDIOLOGY, 2014, 35 (01) : 140 - 148
  • [44] POTENTIALLY LIFE-THREATENING ADVERSE EFFECT OF ANTISEIZURE MEDICATIONS
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2024, 124 (04) : 23 - 23
  • [45] Acute life-threatening drug reactions of the skin
    Mockenhaupt, M.
    HAUTARZT, 2018, 69 (05): : 364 - 375
  • [46] LIFE-THREATENING DRUG OVERDOSE - PRECIPITANTS AND PROGNOSIS
    STERN, TA
    MULLEY, AG
    THIBAULT, GE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (15): : 1983 - 1985
  • [47] LIFE-THREATENING SIMILARITY IN DRUG PACKAGING - REPLY
    CROWLEY, TA
    BARLOW, AL
    ANESTHESIOLOGY, 1982, 56 (06) : 491 - 491
  • [48] Multiple life-threatening fainting episodes: Fatal systemic mastocytosis
    Confino-Cohen, R
    Zilber, M
    Goldberg, A
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (10): : 752 - 753
  • [49] FROM FATAL BLEEDING TENDENCY TO LIFE-THREATENING RISK OF THROMBOSIS
    SCHNEIDER, W
    RUNDE, V
    AUL, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1991, 116 (51-52) : 1971 - 1975
  • [50] A life-threatening rash induced by an inconspicuous drug
    Serban, E. D.
    Bucur, S.
    Ciurduc, M.
    Mutu, C.
    Savu, A.
    Constantin, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S192 - S192